Tag Archives: NSCLC

Using a genetic signature to overcome chemotherapy-resistant lung cancer

Patients with non-small cell lung cancer (NSCLC) often respond to standard chemotherapy, only to develop drug resistance later, and with fatal consequences. But what if doctors could identify those at greatest risk of relapse and provide a therapy to overcome … Continue reading

Posted in Research | Tagged , , | Leave a comment

Race, hospital, insurance status all factors in how lung cancer is treated

African Americans, Hispanics, and those who receive care at a community hospital are all significantly less likely than other patients to receive treatment for early stage non-small cell lung cancer, according to a report in the┬áJournal of Thoracic Oncology. “We … Continue reading

Posted in Research | Tagged , , , , , | Leave a comment

Increased overall survival for advanced stage non-small cell lung cancer patients is associated with availability of less toxic chemotherapy

A 10-year population-based study shows that increased availability of better systemic chemo- and targeted-therapies for patients with advanced non-small cell lung cancer (NSCLC) coincides with increased usage of these therapies. This in turn leads to a significant increase in overall … Continue reading

Posted in Review | Tagged , , , , , , , | Leave a comment

Hormone therapy linked to better survival after lung cancer diagnosis in women

Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference. The combination of estrogen plus progesterone and the use … Continue reading

Posted in Research | Tagged , , , | Leave a comment